Modelling overall survival in immunotherapy using parametric techniques: avelumab in previously treated metastatic Merkel cell carcinoma

Authors:

Bullement A, Amin A, Stapelkamp C, Willis A, Lilley C, Hatswell A, Pescott C and Bharmal M.

Publication type:

Conference Proceedings – Presentation

Publication Name:

ISPOR Europe 2018

Citation:

Bullement A, Amin A, Stapelkamp C, Willis A, Lilley C, Hatswell A, Pescott C and Bharmal M. Modelling overall survival in immunotherapy using parametric techniques: avelumab in previously treated metastatic Merkel cell carcinoma. ISPOR Europe 2018. Barcelona, Spain. 12-14 November 2018. Oral Presentation MO2.

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies